Alpha 2.0
Login Register
» Authors » Matteo Candeloro

Matteo Candeloro

Explore the profile of Matteo Candeloro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 520
Followers 0
Related Specialties
Hematology
General Medicine
Cardiology & Vascular Diseases
Top 10 Co-Authors
Marcello Di Nisio
Ettore Porreca
Nicola Potere
Emanuele Valeriani
Sam Schulman
Walter Ageno
Nick van Es
Camilla Federici
Marco Tana
Anne W S Rutjes
Published In
J Thromb Haemost
Thromb Res
Cochrane Database Syst Rev
J Thromb Thrombolysis
Semin Thromb Hemost
Affiliations
Soon will be listed here.
Recent Articles
1.
Role for neurological and immunological resilience in the pathway of the aging muscle powerpenia: InCHIANTI study longitudinal results
Pellegrino R, Paganelli R, Di Iorio A, Candeloro M, Volpato S, Bandinelli S, et al.
Geroscience . 2025 Jan; PMID: 39885114
The neuromuscular junction shows several degenerative changes with aging, resulting in a reduction of transmission efficacy. These changes, paired with low-grade chronic inflammation, were considered triggers of the aging muscle...
2.
Catheter-related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs
Girardi L, Di Nisio M, Candeloro M, Valeriani E, Ageno W
Eur J Clin Invest . 2024 Sep; 55(1):e14311. PMID: 39262322
Background: Catheter-related thrombosis (CRT) is one of the major complications affecting patients with indwelling venous catheters, usually involving the upper extremity deep venous system. This condition can lead to potentially...
3.
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey
Potere N, Mahe I, Angchaisuksiri P, Cesarman-Maus G, Tan C, Rashid A, et al.
J Thromb Haemost . 2024 Apr; 22(7):1973-1983. PMID: 38582384
Background: Venous thromboembolism (VTE) is a major preventable cause of morbidity, disability, and mortality in subjects with cancer. A global appraisal of cancer-associated VTE education and awareness is not available....
4.
Drugdrug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review
Candeloro M, Carlin S, Shapiro M, Douketis J
Res Pract Thromb Haemost . 2023 May; 7(3):100137. PMID: 37122531
Background: Direct oral anticoagulants (DOACs) are widely used in patients with atrial fibrillation and venous thromboembolism. However, DOACs have important potential drug-drug interactions (DDIs) with several classes of drugs. In...
5.
Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review
Gorman J, Candeloro M, Schulman S
Thromb Haemost . 2023 Apr; 123(10):966-975. PMID: 37015326
Background:  There are limited data on anticoagulant management of acute venous thromboembolism (VTE) after spontaneous intracranial hemorrhage (ICH). Methods:  We reviewed retrospectively all cases diagnosed with VTE during hospitalization for...
6.
Prognostic role of different findings at echocardiography in acute pulmonary embolism: a critical review and meta-analysis
Cimini L, Candeloro M, Plywaczewska M, Maraziti G, Di Nisio M, Pruszczyk P, et al.
ERJ Open Res . 2023 Apr; 9(2). PMID: 37009027
Background: Right ventricle dysfunction (RVD) at echocardiography predicts mortality in patients with acute pulmonary embolism (PE), but heterogeneous definitions of RVD have been used. We performed a meta-analysis to assess...
7.
Age- versus clinical pretest probability-adjusted D-dimer to rule out lower-extremity deep vein thrombosis in ambulatory patients with active cancer
Di Nisio M, Candeloro M, Potere N, Federici C, Rutjes A, Guglielmi M, et al.
Thromb Res . 2023 Mar; 225:22-27. PMID: 36921435
Background: In patients with suspected deep vein thrombosis (DVT), D-dimer thresholds adjusted to age or clinical pretest probability (CPTP) increase the proportion of patients in whom DVT can be safely...
8.
Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis
Candeloro M, Valeriani E, Monreal M, Ageno W, Riva N, Schulman S, et al.
J Thromb Haemost . 2023 Mar; 21(6):1592-1600. PMID: 36907381
Background: The clinical relevance and management of incidental splanchnic vein thrombosis (SVT) remain poorly defined. Objectives: The objectives of this study were to evaluate the clinical course of incidental SVT...
9.
Anamnestic frailty phenotype and adverse outcomes in patients treated with direct oral anticoagulants: Validation and comparative performance with frailty phenotype
Candeloro M, Di Nisio M, Potere N, Federici C, Auciello R, Porreca E
Arch Gerontol Geriatr . 2023 Jan; 108:104945. PMID: 36716647
Aims: The anamnestic frailty phenotype (AFP) is a quick, instrument-free tool derived from frailty phenotype (FP). We prospectively evaluated the discriminative capacity and prognostic value of AFP in ambulatory patients...
10.
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis
Valeriani E, Paciullo F, Porfidia A, Pignatelli P, Candeloro M, Di Nisio M, et al.
J Thromb Haemost . 2023 Jan; 21(2):284-293. PMID: 36700511
Background: Retinal vein occlusion (RVO) represents a common thrombotic disorder. Objectives: In this meta-analysis, we evaluated the efficacy and safety of anticoagulant and antiplatelet therapy in RVO. Methods: MEDLINE and...